About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

D-cycloserine for Major Depressive Disorder

NCT00408031·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Herzog Hospital

With

National Alliance for Research on Schizophrenia and Depression

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

DSM-IV diagnosis of major depression .
HAMD scale score of ≥20 despite at least two adequate antidepressant treatment trials during the current episode.

You may not be if

Underwent ECT treatment during the 3 months preceding the study.
Change in psychotropic medications doses during the 3 weeks preceding the study.
Concurrent unstable medical or neurological illness.
Patients are judged to be potentially violent towards themselves or others, or have a history of drug/alcohol abuse.

The record

StatusCompleted

PhasePhase 2

Taking part26

StartedJan 2007

UpdatedAug 3, 2012

Conditions

Major Depressive Disorder

Where2

Ezrath Nashim - Herzog Memorial Hospital & Community Clinics
Jerusalem, Israel
Ezrath Nashim - Herzog Memorial Hospital
Jerusalem, Israel

Clareo Health | D-cycloserine for Major Depressive Disorder